Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells

Citation
Y. Lavie et al., Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells, ANTICANC R, 21(2A), 2001, pp. 1189-1194
Citations number
26
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
21
Issue
2A
Year of publication
2001
Pages
1189 - 1194
Database
ISI
SICI code
0250-7005(200103/04)21:2A<1189:IEOSAO>2.0.ZU;2-C
Abstract
Intrinsic or acquired resistance of rumor cells to multiple cytotoxic drugs (multidrug resistance. MDR) is a major cause of failure of cancer chemothe rapy. MDR is often caused by elevated expression of drug transporters such as P-glycoprotein (P-gp) or multidrug resistance protein (MRP). A number of compounds, termed chemosensitizers, have little or no cytotoxic action of their own, but inhibit (P-gp) or MRP-mediated drug export and are capable o f sensitizing MDR cells to the cytotoxic effects of chemotherapeutic drugs. Here we examined the ability of steroidal alkaloids of plant origin, namel y the Veratrum sp. alkaloid cyclopamine and the Lycopersicon sp. alkaloid t omatidine, to act as potent and effective chemosensitizers in multidrug res istant tumor cells. Drug uptake was determined by measuring accumulation of tetramethylrosamine in multidrug resistant NCI AdrR human adenocarcinoma c ells. Resistance to adriamycin and vinblastine was determined by utilizing the MTT cell survival assay. Cyclopamine and tomatidine elevate tetramethyl rosamine uptake by NCI AdrR cells and sensitize the cells to the cytotoxic action of adriamycin and vinblastine. In both cases these agents are compar able in patency and efficacy to verapamil, a reversal agent commonly used i n MDR research. It is concluded that steroidal alkaloids of plant origin ac t as inhibitors of P-gp-mediated drug transport and multidrug resistance an d therefore may serve as chemosensitizers in combination chemotherapy with conventional cytotoxic drugs for treating multidrug resistant cancer.